DK2003202T3 - G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf - Google Patents

G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf

Info

Publication number
DK2003202T3
DK2003202T3 DK08165936.9T DK08165936T DK2003202T3 DK 2003202 T3 DK2003202 T3 DK 2003202T3 DK 08165936 T DK08165936 T DK 08165936T DK 2003202 T3 DK2003202 T3 DK 2003202T3
Authority
DK
Denmark
Prior art keywords
prostate cancer
phor
coupled receptor
regulated
applications
Prior art date
Application number
DK08165936.9T
Other languages
English (en)
Inventor
Arthur B Raitano
Daniel E H Afar
Aya Jakobovits
Mary Faris
Rene S Hubert
Steve C Mitchell
Douglas C Saffran
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of DK2003202T3 publication Critical patent/DK2003202T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK08165936.9T 1999-10-05 2000-10-05 G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf DK2003202T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15790299P 1999-10-05 1999-10-05
EP00967335A EP1220913B1 (en) 1999-10-05 2000-10-05 G protein-coupled receptor up-regulated in prostate cancer and uses thereof

Publications (1)

Publication Number Publication Date
DK2003202T3 true DK2003202T3 (da) 2012-01-16

Family

ID=22565799

Family Applications (2)

Application Number Title Priority Date Filing Date
DK08165936.9T DK2003202T3 (da) 1999-10-05 2000-10-05 G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf
DK00967335T DK1220913T3 (da) 1999-10-05 2000-10-05 G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK00967335T DK1220913T3 (da) 1999-10-05 2000-10-05 G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf

Country Status (13)

Country Link
EP (2) EP2003202B1 (da)
JP (2) JP4272376B2 (da)
AT (2) ATE417104T1 (da)
AU (2) AU779685B2 (da)
CA (1) CA2385032C (da)
CY (2) CY1110059T1 (da)
DE (1) DE60041073D1 (da)
DK (2) DK2003202T3 (da)
ES (2) ES2316387T3 (da)
HK (1) HK1048494B (da)
IL (1) IL147952A0 (da)
PT (2) PT2003202E (da)
WO (1) WO2001025434A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
EP1539805A4 (en) * 2001-05-15 2005-11-16 Agensys Inc NUCLEIC ACIDS AND CORRESPONDING PROTEINS SAID 101P3A11 OR PHOR-1 FOR THE TREATMENT AND DETECTION OF CANCERS
DK1864131T3 (da) * 2005-03-03 2011-10-31 Chemcom Sa Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
US20100015101A1 (en) * 2006-03-28 2010-01-21 Noriyuki Sato Novel tumor antigen peptides
JP2012196211A (ja) * 2012-04-10 2012-10-18 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
EP0489149B1 (en) 1990-06-27 2001-10-17 Princeton University Probes for detecting mutant p53
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
DE69532127T2 (de) 1994-07-20 2004-08-26 Genetics Institute, Inc., Cambridge Interaktions-fullensysteme zum nachweis von protein-interaktionen
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
CA2217545A1 (en) 1995-04-11 1996-10-17 Marc Vidal Reverse two-hybrid systems
AU2662695A (en) * 1995-06-05 1996-12-24 Human Genome Sciences, Inc. Human g-protein receptor hpraj70
US5928868A (en) 1996-04-26 1999-07-27 Massachusetts Institute Of Technology Three hybrid screening assay
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
CA2271234C (en) 1996-10-15 2011-04-26 The Regents Of The University Of California Animal models of human prostate cancer progression
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
EP0942968B1 (en) 1996-12-03 2008-02-27 Amgen Fremont Inc. Fully human antibodies that bind EGFR
WO2000004149A2 (en) * 1998-07-14 2000-01-27 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
EP1000148A2 (en) * 1997-08-01 2000-05-17 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
CA2345045A1 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Also Published As

Publication number Publication date
JP4875671B2 (ja) 2012-02-15
AU7755300A (en) 2001-05-10
IL147952A0 (en) 2002-08-14
AU2005201916A1 (en) 2005-06-02
EP2003202B1 (en) 2011-09-14
DE60041073D1 (de) 2009-01-22
JP4272376B2 (ja) 2009-06-03
PT1220913E (pt) 2009-02-16
AU2005201916B2 (en) 2008-06-19
CA2385032C (en) 2013-12-10
AU2005201916A2 (en) 2005-08-25
DK1220913T3 (da) 2009-03-16
EP1220913A1 (en) 2002-07-10
HK1048494A1 (en) 2003-04-04
CY1110059T1 (el) 2015-01-14
CA2385032A1 (en) 2001-04-12
JP2003511029A (ja) 2003-03-25
WO2001025434A1 (en) 2001-04-12
HK1048494B (zh) 2009-06-12
PT2003202E (pt) 2012-01-02
ATE417104T1 (de) 2008-12-15
ES2316387T3 (es) 2009-04-16
EP2003202A2 (en) 2008-12-17
AU779685B2 (en) 2005-02-03
CY1112202T1 (el) 2015-12-09
ES2371212T3 (es) 2011-12-28
EP2003202A3 (en) 2009-10-21
JP2009050256A (ja) 2009-03-12
ATE524549T1 (de) 2011-09-15
EP1220913B1 (en) 2008-12-10

Similar Documents

Publication Publication Date Title
ATE486938T1 (de) C-typ-lektin-transmembran-antigen, das in menschlichem prostatakrebs exprimiert wird, und verwendungen dieses antigens
ES2202432T3 (es) Factor de crecimiento endotelial vascular b.
AU2001272908A1 (en) Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
WO1999064576A3 (en) Human genes differentially expressed in colon cancer
CY1112202T1 (el) Υποδοχεας συζευγμενος προς g πρωτεϊνη θετικως ρυθμισμενος σε καρκινο προστατη και χρησεις αυτου
SG145559A1 (en) Genes and polypeptides relating to human colon cancers
AU2003225093A8 (en) Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
HUP0400284A2 (hu) Rekombináns, tumorspecifikus ellenanyag és alkalmazása
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
WO2000012702A3 (en) Human genes differentially expressed in colorectal cancer
DE602005025231D1 (de) Gene und polypeptide in verbindung mit brustkrebserkrankungen
Trieb et al. Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells
ATE364315T1 (de) Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
ATE313647T1 (de) Dickdarm spezifische gene und proteine
ATE373711T1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
WO2003023060A3 (de) Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs
WO2001059110A3 (en) 34p3d7: a tissue specific protein highly expressed in prostate cancer
WO2001090157A8 (en) 98p7c3: homeodomain protein highly expressed in various cancers
US6171818B1 (en) Protein having an anti-tumoral effect
Hogen et al. EP008/# 378 Comparative genomic analysis of ovarian clear cell carcinoma patients with and without a second primary malignancy
ATE340256T1 (de) Säuger-krebszelle und menschliches protoonkogen tragender transgener säuger sowie kit zur krebsdiagnose mit dem protoonkogen
EP2299268A3 (en) Methods and compositions for diagnosing hepatocellular carcinoma
EP1243653A3 (en) E25a protein, methods for producing and use thereof
GB0118551D0 (en) Proteins genes and their use for diagnosis and treatment of breast cancer